Dynamic contrast-enhanced CT in patients treated with sorafenib and erlotinib for non-small cell lung cancer: a new method of monitoring treatment?

Joline S. W. Lind; Martijn R. Meijerink; Anne-Marie C. Dingemans; Cornelis van Kuijk; Michel C. Öllers; Dirk de Ruysscher; Pieter E. Postmus; Egbert F. Smit

首页> 外文期刊>European Radiology >Dynamic contrast-enhanced CT in patients treated with sorafenib and erlotinib for non-small cell lung cancer: a new method of monitoring treatment?

【24h】

Dynamic contrast-enhanced CT in patients treated with sorafenib and erlotinib for non-small cell lung cancer: a new method of monitoring treatment?

机译：索拉非尼和厄洛替尼治疗非小细胞肺癌患者的动态对比增强CT：监测治疗的新方法？

获取原文

获取原文并翻译 | 示例

获取外文期刊封面目录资料

开具论文收录证明 >>

文献代查 >>

文献数据库（团队版） >>

页面导航

摘要
著录项
引文网络
相似文献
相关主题

摘要

Objective We investigated the feasibility of serial dynamic contrast-enhanced computed tomography (DCE-CT) in patients with advanced/metastatic non-small cell lung cancer (NSCLC) receiving anti-angiogenic (sorafenib) and anti-EGFR (erlotinib) treatment, and correlated tumour blood flow (BF) with treatment outcome.

机译：目的我们研究了连续动态对比增强计算机断层扫描（DCE-CT）在接受抗血管生成（索拉非尼）和抗EGFR（厄洛替尼）治疗的晚期/转移性非小细胞肺癌（NSCLC）患者中的可行性，以及肿瘤血流量（BF）与治疗结果相关。

著录项

来源
《European Radiology》 |2010年第12期|p.2890-2898|共9页
作者
Joline S. W. Lind; Martijn R. Meijerink; Anne-Marie C. Dingemans; Cornelis van Kuijk; Michel C. Öllers; Dirk de Ruysscher; Pieter E. Postmus; Egbert F. Smit;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. Dynamic contrast-enhanced CT in patients treated with sorafenib and erlotinib for non-small cell lung cancer: a new method of monitoring treatment? [J] . Lind JS, Meijerink MR, Dingemans AM, European radiology . 2010,第12期

机译：索拉非尼和厄洛替尼治疗非小细胞肺癌患者的动态对比增强CT：监测治疗的新方法？
2. Inter-reader reproducibility of dynamic contrast-enhanced magnetic resonance imaging in patients with non-small cell lung cancer treated with bevacizumab and erlotinib [J] . van den Boogaart Vivian E. M., de Lussanet Quido G., Houben Ruud M. A., Lung cancer: Journal of the International Association for the Study of Lung Cancer . 2016,第Null期

机译：动态对比增强磁共振成像在贝伐单抗和厄洛替尼治疗的非小细胞肺癌患者中的阅读器间再现性
3. Sorafenib and continued erlotinib or sorafenib alone in patients with advanced non-small cell lung cancer progressing on erlotinib: A randomized phase II study of the Sarah Cannon Research Institute (SCRI) [J] . David R. Spigel, Mark S. Rubin, Victor G. Gian, Lung cancer: Journal of the International Association for the Study of Lung Cancer . 2017,第期

机译：Sorafenib和持续的奥拉替尼或索拉非尼免于欧洲毒素进展的晚期非小细胞肺癌的患者：Sarah Cannon Research Institute（Scri）的随机期II研究
4. IMPROVING PREDICTION OF SURVIVAL USING CT-BASED TUMOR CHARACTERISTICS IN PATIENTS TREATED FOR METASTATIC NON-SMALL CELL LUNG CANCER [C] . WALKER H. LAND JR., ALAN LITWIN, DAN MARGOLIS, Artificial Neural Networks in Engineering Conference . 2010

机译：基于CT基肿瘤特征改善对转移性非小细胞肺癌的患者的肿瘤特征预测
5. The cost effectiveness of screening for early stage lung cancer and the testing and treatment of molecular subgroups among non-small cell lung cancer patients in the province of ontario, canada [D] . Thao, Mallory. 2014

机译：加拿大安大略省非小细胞肺癌患者早期肺癌筛查的成本效益及分子亚群的检测和治疗
6. Dynamic contrast-enhanced CT in patients treated with sorafenib and erlotinib for non-small cell lung cancer: a new method of monitoring treatment? [O] . Joline S. W. Lind, Martijn R. Meijerink, Anne-Marie C. Dingemans, -1

机译：索拉非尼和厄洛替尼治疗非小细胞肺癌患者的动态对比增强CT：监测治疗的新方法？
7. Dynamic contrast-enhanced CT in patients treated with sorafenib and erlotinib for non-small cell lung cancer: a new method of monitoring treatment? [O] . Lind, Joline S. W, Meijerink, Martijn R, Dingemans, Anne-Marie C, 2010

机译：索拉非尼和厄洛替尼治疗非小细胞肺癌患者的动态对比增强CT：监测治疗的新方法？

Dynamic contrast-enhanced CT in patients treated with sorafenib and erlotinib for non-small cell lung cancer: a new method of monitoring treatment?

摘要

著录项

引文网络

相似文献

相关主题

期刊订阅